# 当代年轻人为什么尿酸会高？
- 点赞数：6138
- 更新时间：2023年02月23日00时24分12秒
- 回答url：https://www.zhihu.com/question/451814736/answer/2056309917
<body>
 <p></p>
 <figure data-size="normal">
  <img src="https://picx.zhimg.com/50/v2-f326b0df58fdb56035729628cd4aa79b_720w.jpg?source=1940ef5c" data-rawwidth="1080" data-rawheight="1118" data-size="normal" data-caption="" data-original-token="v2-f326b0df58fdb56035729628cd4aa79b" data-default-watermark-src="https://picx.zhimg.com/50/v2-e9681a65401cfd1902d44fb06e2c9425_720w.jpg?source=1940ef5c" class="origin_image zh-lightbox-thumb" width="1080" data-original="https://picx.zhimg.com/v2-f326b0df58fdb56035729628cd4aa79b_r.jpg?source=1940ef5c">
 </figure>
 <p data-pid="8bpSGvaS">这篇文章只是介绍尿酸的生理/病理知识。</p>
 <p data-pid="IQzlWC-1">小结：</p>
 <ul>
  <li data-pid="NVLjaCTm">尿酸主要是嘌呤转化来的，所以关注尿酸一般要关注嘌呤；</li>
  <li data-pid="_TZ7P8Ij">尿酸的来源包括嘌呤的饮食摄入/自身合成增加，去路包括尿液/肠道排泄；</li>
  <li data-pid="xkw5BMzP">尿酸水平取决于合成 和排泄之间的差值；</li>
  <li data-pid="o6-34XBe">现有的病理研究认为，尿酸高主要是排泄不畅为主；</li>
  <li data-pid="AEN_Oij0">排泄不畅的主要原因，是遗传。</li>
 </ul>
 <hr>
 <h2>一、尿酸的来源和排泄</h2>
 <p data-pid="GoQzUM_U">嘌呤是人体遗传物质核酸的组成部分，也是能量代谢的产物。各类嘌呤在相应的酶（如黄嘌呤氧化酶、鸟嘌呤脱氨酶、黄嘌呤氧化酶）的作用下被转化为尿酸，所以我们在考虑尿酸水平的时候，<b>主要考虑嘌呤</b>。</p>
 <p data-pid="pAG8JbT5">嘌呤有两种来源，外源性和内源性的。外源性通常是吃下去的，嘌呤是细胞核酸的组成部分，动植物都含有细胞结构，大多数都有细胞核；内源性通常是自身代谢产生，源于人体内蛋白质分解代谢、细胞死亡、一些化合物分解代谢（如ATP）等。</p>
 <p data-pid="-4btXNAz">常见的数据表明人体20%的嘌呤来自于食物，80%来自于内源性生成。</p>
 <p data-pid="PMUD3Q60">尿酸的排泄：</p>
 <p data-pid="ib9F3IJe">主要在肝脏产生（小肠和其他组织也能产生一些），通过肾脏/泌尿系统排泄（排出约2/3）[59，60]，次要通过肠道排泄（排出约1/3）[24]。</p>
 <figure data-size="normal">
  <img src="https://pica.zhimg.com/50/v2-fc38ece9ca9b73e99cfd5a93a6165a53_720w.jpg?source=1940ef5c" data-rawwidth="784" data-rawheight="589" data-size="normal" data-caption="" data-original-token="v2-fc38ece9ca9b73e99cfd5a93a6165a53" data-default-watermark-src="https://picx.zhimg.com/50/v2-593e2f3db63177afa25eaae3d0a0bebf_720w.jpg?source=1940ef5c" class="origin_image zh-lightbox-thumb" width="784" data-original="https://pic1.zhimg.com/v2-fc38ece9ca9b73e99cfd5a93a6165a53_r.jpg?source=1940ef5c">
 </figure>
 <p class="ztext-empty-paragraph"><br></p>
 <p data-pid="aYT59rKX">尿酸一边产生，一边排泄，血液尿酸水平取决于两者之差。</p>
 <p data-pid="2Wl8q3Am">如果产生=排泄，则达到动态平衡；</p>
 <p data-pid="HZsR2q0r">如果产生＞排泄，则尿酸水平升高，长期可能形成高<b>尿酸血症</b>；</p>
 <p data-pid="gEEvF_at">如果产生＜排泄，则尿酸水平过低，长期可能形成<b>低尿酸血症</b>。</p>
 <figure data-size="normal">
  <img src="https://pic1.zhimg.com/50/v2-e9e73bac191fd401ff57611294a1624f_720w.jpg?source=1940ef5c" data-rawwidth="906" data-rawheight="285" data-size="normal" data-caption="" data-original-token="v2-e9e73bac191fd401ff57611294a1624f" data-default-watermark-src="https://picx.zhimg.com/50/v2-b80e36a66a6bfb1ac1ea128a51bce9cd_720w.jpg?source=1940ef5c" class="origin_image zh-lightbox-thumb" width="906" data-original="https://picx.zhimg.com/v2-e9e73bac191fd401ff57611294a1624f_r.jpg?source=1940ef5c">
 </figure>
 <hr>
 <h2>二、尿酸在排泄过程中，由肾回收90%</h2>
 <p data-pid="43_69rZi">大多数哺乳动物，都不直接排出尿酸。它们体内有相应的基因，可以编码出一种蛋白：尿酸酶（Uricase），可以把尿酸进一步氧化为尿囊素，这是一种溶解度很高的物质，可以轻易随尿液排出体外[104]。也就是说，对大多数哺乳动物而言，尿酸只是代谢的中间产物，最终排出的是尿囊素。</p>
 <p data-pid="5EvT5BHG">我们人类/灵长类曾经也是这样，但是后来变了。我们祖先的尿酸酶基因发生突变[2，21，22，119]，使我们不能再产生尿酸酶[22]，无法把尿酸氧化为尿囊素。</p>
 <p data-pid="XqM5t3EV">有趣的是，现代人和高等灵长类动物还保有非功能性尿酸酶基因（也叫伪基因）[1]。我们不但不产生尿酸酶了，还用肾脏把尿液中的尿酸<b>重吸收90%</b>左右[23，24]，只有10%左右排出体外。</p>
 <figure data-size="normal">
  <img src="https://pic1.zhimg.com/50/v2-a87871f56992fc6484b9b5fa8b822831_720w.jpg?source=1940ef5c" data-rawwidth="648" data-rawheight="230" data-size="normal" data-caption="" data-original-token="v2-a87871f56992fc6484b9b5fa8b822831" data-default-watermark-src="https://picx.zhimg.com/50/v2-c8ac7493de3e8659f69c86a8e82202c8_720w.jpg?source=1940ef5c" class="origin_image zh-lightbox-thumb" width="648" data-original="https://picx.zhimg.com/v2-a87871f56992fc6484b9b5fa8b822831_r.jpg?source=1940ef5c">
 </figure>
 <hr>
 <h2>三、向尿酸致敬！</h2>
 <p data-pid="x8upLTh6">虽然现在人类站在食物链顶峰，在其他动物面前，我们像神一样掌握了生杀大权，但我们的祖先其实比较弱势。在非常遥远的年代（6百万年以前乃至更早），我们的祖先是灵长类，主要住在树上。生物学家认为这是一个相对安全的区域，这就意味着，我们的祖先在食物链的位置中等偏下，需要依靠树木躲避猛兽。</p>
 <p data-pid="GpcslYb6">地位不高，意味着我们的祖先其实大多数时候，很难从动物性食物中获取脂肪。虽然它们能抓到各种小型动物（青蛙，蜘蛛，轮虫，蛇，蜥蜴等），但这些小型动物的脂肪含量，通常都很低（贝爷经常抓住它们，然后说高蛋白低脂肪）。</p>
 <p data-pid="0pFJX9rL">在约一千多万年前，我们的祖先是靠果糖来储存脂肪的[3，4，125]。果糖在肝脏代谢，先转为果糖-1-磷酸，再转为三磷酸甘油或长链脂肪酸[111，112，113]。这样我们的祖先就能在吃不到大型动物的前提下，只靠吃果子就获得脂肪，这样风险小，安全高效，对生存非常重要。</p>
 <p data-pid="FdEz5mAQ">其实，不光是我们的祖先，很多草食动物都靠果糖来储存足够的脂肪过冬。</p>
 <p data-pid="EcSy1Ivf">但后来情况变了，在1200-1400万年前发生了<b>“中新世纪灾难”</b>（Middle Miocene DisRU）[125]，全球气温大幅度下降，大量动植物死亡，我们祖先的食物大量减少。</p>
 <p data-pid="GfQkaGFY">怎么办呢？利用尿酸，回收尿酸。因为尿酸可以激活一个过程，把相对不容易转化为脂肪的葡萄糖，也转化为果糖[118]。</p>
 <p data-pid="SQaRp-Hy">步骤是：</p>
 <ul>
  <li data-pid="RrIKRiW6">尿酸激活AR（醛糖还原酶）[116，117]；</li>
  <li data-pid="kBEQHK7w">AR 将葡萄糖转为山梨醇；</li>
  <li data-pid="IrIPcZ1O">山梨醇在山梨醇脱氢酶（SDH）的作用下，转化为果糖；</li>
 </ul>
 <p data-pid="oIijnrU3">这样，葡萄糖就在尿酸的作用下，成了果糖[114，115]。接下来，我们的祖先再把果糖转为脂肪。更棒的是，果糖代谢为脂肪的过程中，因为能量代谢的问题，又会产生更多的嘌呤，意味着更多的尿酸。</p>
 <p data-pid="wBomRfK9">这就有点像成了一个循环：</p>
 <ul>
  <li data-pid="rLC6_mdM">果糖转化脂肪的过程中，产生嘌呤-尿酸；</li>
  <li data-pid="7EfioyCa">尿酸又把更多的葡萄糖转化为果糖；</li>
  <li data-pid="z9jkzzkA">果糖再转化为脂肪，过程再产生尿酸......</li>
 </ul>
 <p data-pid="2u3io1O3">如此循环往复，就达到了脂肪产量的最大化[125]。这就是我们的祖先要“废弃”尿酸酶的原因，因为<b>尿酸有个重要作用：促进脂肪堆积</b>[5，6]。</p>
 <p data-pid="6EuPncTy">Laura等人证实了尿酸促进脂肪堆积这件事：他们用尿酸来处理细胞（HepG2细胞），发现尿酸能提高一些酶的活性（SDH酶等等）；这些酶的活性提高，可以促进葡萄糖向果糖的转化，从而提高甘油三酯在体内（特别是脂肪）的积累[9，，127，128]。</p>
 <figure data-size="normal">
  <img src="https://picx.zhimg.com/50/v2-b00aebca810e92e0485344abcfc296e1_720w.jpg?source=1940ef5c" data-rawwidth="937" data-rawheight="529" data-size="normal" data-caption="" data-original-token="v2-b00aebca810e92e0485344abcfc296e1" data-default-watermark-src="https://pic1.zhimg.com/50/v2-07aea98ca0f1273078e0a2b881cebccc_720w.jpg?source=1940ef5c" class="origin_image zh-lightbox-thumb" width="937" data-original="https://picx.zhimg.com/v2-b00aebca810e92e0485344abcfc296e1_r.jpg?source=1940ef5c">
 </figure>
 <p data-pid="XzEI16KL">所以，我们的祖先身上发生的尿酸酶基因突变（失去了尿酸酶），不再把尿酸转化为尿囊素排出，而是回收尿酸，用来获取更多的脂肪储存[125，127，128]。</p>
 <p data-pid="c6LVyevR">演化，是为了生存。</p>
 <p data-pid="WCs4l9ej">更令人服气的是，尿酸的作用不仅限于此，还有<b>维持血压的作用</b>。虽然维持血压，在我们现代人看来不是个事，但是在远古时候可不那么容易，因为那时候没有制盐手段，很难吃到足够的盐，就不容易维持血压（这就是为什么人体要保钠排钾）。</p>
 <p data-pid="MlBv0OLc">还有，当较长时间食物匮乏、饥饿时等，哺乳动物容易发生低血压[17，18，19]，所以尿酸维持血压的作用就显得特别重要。尿酸通过一氧化氮来影响内皮血管功能[10，11，12，13，14]，或是影响肾素-血管紧张素系统[15，16]来维持血压。</p>
 <p data-pid="tUMkVz1G">注意，果糖-尿酸-脂肪的相关代谢，都在肝脏发生，因此喝了太多的甜饮料（含有许多果糖）容易诱发脂肪肝；尿酸高的人别喝甜饮料和果糖，这是常识。</p>
 <p data-pid="yoRX-IEg">但是换个角度想，如果不是这套机制，我们的祖先可能早就因为缺乏脂肪和能量，冻死、饿死在中新世纪灾难的冰天雪地里了。那么，也就提前“全剧终”，哪还有现代的人类文明，哪还有拿着手机刷知乎的我们？</p>
 <p data-pid="9PpmoM3F"><b>向尿酸致敬！</b></p>
 <hr>
 <h2>四、尿酸鲜为人知的一面：对神经/大脑有保护作用</h2>
 <p data-pid="di1Bg-eV">由于我们重吸收了90%左右的尿酸，所以导致人类/灵长类比其他哺乳动物血液中的尿酸水平高了接近10倍[46，47，120，121]。</p>
 <p data-pid="-kZH6VvP">人类的演化是沿着一条“智力属性”的路线走的，所以大脑和神经对我们来说特别重要。Havelock Ellis等人很早就提出，尿酸可能与人类的智力水平有关[126]。有些研究者认为，人类比其他哺乳动物尿酸水平高，可能会是我们比它们更长寿的原因之一[48]，尿酸还有<b>抗氧化和保护神经的作用。</b></p>
 <p data-pid="l-iwPvSn">有利的研究显示，尿酸约占血浆抗氧化活性的60%，能维持血压和抗氧化应激的稳定性[25，26]；尿酸能清除氧自由基[122]，防止维生素C在体内被氧化[123，124]；<b>生理浓度下的</b>尿酸能降低人体内的一些过氧化反应，保护红细胞[20]、防止低密度脂蛋白的氧化和超氧化物歧化酶的失活[27]。</p>
 <p data-pid="GnY9lafY">尿酸可以多形核血和红细胞产生的自由基所介导的器官损伤[142]，可以保护重要的抗氧化酶——超氧化歧化酶的结构和功能[143，144]，可以保护DNA减少氧化损伤[145]；对包含了健康人、吸烟者、1型糖尿病患者和心血管疾病患者在内的不同人群的研究数据表明，对血液中输入尿酸，可显著改善总抗氧化能力和保存血管内皮功能[146，147，148，149，150].</p>
 <p data-pid="fyydzUIa">有趣的是，不但正常浓度的尿酸对人体有保护作用，<b>高尿酸血症</b>也对一些神经系统疾病如阿兹海默症有保护作用[7，30，43]；反过来，低尿酸血症与神经系统疾病密切相关[7]，可增加老年痴呆症、帕金森病、多发性硬化症、精神分裂症和痴呆症的风险[44，45，46]。</p>
 <p data-pid="JGz4frI9">所以，尿酸酶基因的丢失、人体对尿酸的回收，是精打细算的结果。</p>
 <hr>
 <h2>五、高尿酸：排泄不畅</h2>
 <p data-pid="gxOvhA7J">前瞻性流行病学研究指出，尿酸升高的病理机制复杂，与许多疾病/亚健康状态有关，如氧化应激、肥胖、高血压、代谢综合征、慢性肾病等[73，74，75，76，77，78]。不良生活习惯，久坐、熬夜、铅、血液中铁含量过高等很多因素也可导致尿酸升高。但是归根到底，尿酸水平是取决于尿酸合成（包括食物摄入）和尿酸排泄的<b>差值</b>[72]。</p>
 <p data-pid="uFzRmmf6">那尿酸高，到底是尿酸生成太多，还是尿酸排泄不畅？我们能看到一些证据：</p>
 <ul>
  <li data-pid="eA3Cs3gq">肾功能正常的人食用富含嘌呤的食物后，尿酸排泄增加50%以上[83]；</li>
  <li data-pid="zu-kZzD-">高尿酸血症患者的尿酸清除率和排泄量都比正常人低[85]；</li>
  <li data-pid="zY9BF-qW">在肥胖、胰岛素抵抗和高血压患者中，尿酸的升高主要是由于肾排泄受损所致[42，87]；</li>
 </ul>
 <p data-pid="zYVkX5oC">目前主流科学认为，<b>尿酸排泄不畅（而非摄入/合成过多）是高尿酸问题的主因</b>[79，80，81，82，84]。</p>
 <hr>
 <h2><b>六、排泄不畅，遗传因素占了重头</b></h2>
 <p data-pid="v4g2Iah8">根据我国的一项研究[86]，<b>高尿酸的遗传力为0.63</b>（1表示完全由遗传决定，0表示完全由环境因素决定），<b>这表明遗传因素是尿酸高的主因</b>。</p>
 <p data-pid="C1YZZSLV">Adrienne等人对457690人进行了跨种族血清尿酸的分析，确定了183个与尿酸代谢相关的基因点位[89]，也说明遗传对尿酸水平具有深远影响。</p>
 <p data-pid="OgEfCQJu">遗传对尿酸水平的影响，主要是通过各类转运尿酸的蛋白来实现的。肾脏重吸收了每天尿液中90%的尿酸，这种重吸收，十分依靠上述蛋白；这些蛋白也有自己的DNA，它们受遗传突变、基因表达差异所影响（比如这些蛋白是运载尿酸的货车，那么DNA就是制造这些货车的工厂，货车的数量和性能取决于工厂的产量和生产质量）。</p>
 <p data-pid="nA2uQq36">我们看几种典型的转运蛋白：</p>
 <h3><b>第一种，ABCG2</b></h3>
 <p data-pid="y8eR94Tc">ABCG2的全名是ATP binding cassette subfamily member2，它是一种尿酸转运体蛋白[66，67，68]，位于肾、肠等组织的根尖细胞膜上，它依赖ATP作为能量，运载各类化合物。</p>
 <p data-pid="XLzCe135">ABCG2对尿酸在肾脏和肠道中的排泄起重要作用[50，51，52]。它发生功能障碍，会导致肾脏对尿酸的排泄显著减少，这被认为是<b>导致高尿酸血症的主要原因之一。</b></p>
 <p data-pid="-DTdLc1y">Ichida等人研究了了664名男性高尿酸患者[53]，发现在这些人中，<b>71.9%的人都发生了ABCG2基因的突变</b>（突变的是ABCG2上的一个叫Q141K的点位），这说明高尿酸患者中遗传突变是比较普遍的。</p>
 <p data-pid="Nj5no_ty">Matsuo等人对90例高尿酸血症患者的ABCG2基因进行了突变分析[52]，发现6六个突变点位。它们对于尿酸水平有显著影响：例如ABCG2基因上的Q126X点位突变，可导致痛风风险大幅度提升，增加<b>597%。</b>这6个点位，在下图中是橙色字体。</p>
 <figure data-size="normal">
  <img src="https://picx.zhimg.com/50/v2-6f9ee359d5a623721113c6501cc8ed82_720w.jpg?source=1940ef5c" data-rawwidth="828" data-rawheight="752" data-size="normal" data-caption="" data-original-token="v2-6f9ee359d5a623721113c6501cc8ed82" data-default-watermark-src="https://picx.zhimg.com/50/v2-9e246a8d33afee492fcc166f59184260_720w.jpg?source=1940ef5c" class="origin_image zh-lightbox-thumb" width="828" data-original="https://pica.zhimg.com/v2-6f9ee359d5a623721113c6501cc8ed82_r.jpg?source=1940ef5c">
 </figure>
 <p data-pid="q5bKAfTi">理所当然的是，如果ABCG2出现功能障碍，也与慢性肾病存在密切关系[54，55，56，56，57]。ABCG2不光在尿酸的肾脏排泄途径中有核心地位，在肠道尿酸排泄中也是一种重要的转运体[52]。</p>
 <p data-pid="2r0bRkAz">有趣的是，如果如果肾尿酸排泄减少，ABCG2的肠道表达就会增加。当肾脏不能排泄足够的尿酸，人体会试图增加肠道对尿酸的排泄，这在慢性肾病中特别重要，被称为“远程器官通讯”[58]。</p>
 <h3><b>第二种，URAT1</b></h3>
 <p data-pid="1KvD820X">URAT1的中文名为尿酸转运体1[61]，是基因SLC22A12编码的产物，它是含有553个氨基酸的转运蛋白37，38，39，40]。它与另一种名为“钠氢交换调节剂”的蛋白结合作用，在肾脏对尿酸的重吸收中发挥<b>重要作用</b>[37，47，48]<b>。</b></p>
 <p data-pid="J9XpjCTg">URAT1的基因突变会导致URAT1功能失调，这被认为是<b>高尿酸血症的主要原因</b>[41，42]。一项中国的研究发现，人类URAT1基因的启动子中，有<b>雄激素反应元件</b>[82]。</p>
 <p data-pid="wzC1YocQ">什么是激素反应元件？</p>
 <p data-pid="4wAgtspy">我们都知道，激素需要受体，但并不是跟受体结合就完事了。激素和受体结合后，还需要与DNA上的一段区域结合，才能影响DNA——因为蛋白质是DNA表达（制造）出来的。</p>
 <p data-pid="GiuQYSr6">DNA上的这段区域，就是激素反应元件。</p>
 <figure data-size="normal">
  <img src="https://picx.zhimg.com/50/v2-875c3e4447b1c491755d19687af6a914_720w.jpg?source=1940ef5c" data-rawwidth="998" data-rawheight="548" data-size="normal" data-caption="" data-original-token="v2-875c3e4447b1c491755d19687af6a914" data-default-watermark-src="https://picx.zhimg.com/50/v2-4da74c71f3ae34a3a85438275c0c8a83_720w.jpg?source=1940ef5c" class="origin_image zh-lightbox-thumb" width="998" data-original="https://pic1.zhimg.com/v2-875c3e4447b1c491755d19687af6a914_r.jpg?source=1940ef5c">
 </figure>
 <p data-pid="CDvyritl">就尿酸来说，睾酮与受体结合后，坐落于URAT1基因上，增强其表达。更强的URAT1表达意味着男性的URAT1的性能更强，对尿酸的回收更彻底。这在很大程度上解释了为什么男性比女性的尿酸水平更高；所以原作者更直接的说，这是<b>男女之间尿酸差别的根本原因</b>。</p>
 <h3><b>第三种，GLUT9</b></h3>
 <p data-pid="pi_gPadQ">GLUT9中文名葡萄糖转运蛋白9[62，63，64]，是基因SLC2A9编码的产物，其基因广泛存在于人的肾小管近端[8]，有a/b两个亚型[28]。</p>
 <p data-pid="9AT_aFeA">GLUT9最早被认为是转运葡萄糖用的，所以得了个“葡萄糖转运蛋白”的名字。但是后来发现，它在尿酸<b>重吸收过程中发挥了关键作用</b>[31]，因此GLUT9的遗传/功能缺陷可导致高尿酸血症[88]。</p>
 <p data-pid="ds3vPwuB">有趣的是，遗传缺陷不但可能导致高尿酸血症，也可能反过来也可以导致GLUT9过少，肾小管吸收尿酸太少，导致<b>低尿酸血症</b>[32，33，34]。</p>
 <p data-pid="kLc5fxtF">尿酸少了不好吗？</p>
 <p data-pid="E8ww2j7M">是的，我们人类需要生理浓度的尿酸（血压，保护神经系统，抗氧化，维持氧化应激稳态等）。如果尿酸过少，除了容易引发神经系统病变[43，49]，还可能引发<b>肾结石和肾衰竭</b>[35，36]——是的，你没听错，过低的尿酸也可能引起肾病。</p>
 <p data-pid="-GO6H2-D">参与尿酸代谢的转运体还有很多，我们就不一一介绍了。上述知识解释了为什么同样是海鲜啤酒，有些人尿酸达到700，800多，有些人却依旧保持在400多：因为遗传因素影响了上述转运蛋白的数量、活性、功能等，造成了肾脏对尿酸排泄能力的差异。</p>
 <hr>
 <h2>七、孕期/幼年饥荒可能导致尿酸高</h2>
 <p data-pid="pXRiy8LJ">众所周知，1959-1961年中国遭遇了三年自然灾害和大饥荒。张文强等人研究了中国健康与退休纵向研究”(CHARLS)的数据，这些数据中包含了自然灾害期间出生的2383人[127]。</p>
 <p data-pid="DN4NaszP">这些数据指向，在怀孕期间/幼年暴露于饥荒中并在中老年发生肥胖的人，发生高尿酸血症的几率提高三倍以上。</p>
 <figure data-size="normal">
  <img src="https://picx.zhimg.com/50/v2-605174018b7231e489fec922279e26ed_720w.jpg?source=1940ef5c" data-rawwidth="925" data-rawheight="464" data-size="normal" data-caption="" data-original-token="v2-605174018b7231e489fec922279e26ed" data-default-watermark-src="https://picx.zhimg.com/50/v2-2be4163e620f12425a01245b86b74e2e_720w.jpg?source=1940ef5c" class="origin_image zh-lightbox-thumb" width="925" data-original="https://picx.zhimg.com/v2-605174018b7231e489fec922279e26ed_r.jpg?source=1940ef5c">
 </figure>
 <p data-pid="R5nq1OYn">类似的结论也有其他许多研究支持[134，135，136，137]，胎儿期或早年发生营养不良，发生高尿酸血症和肥胖/胰岛素血症的几率更大。其原因被是胎儿在子宫内营养不良、低出生体重低，可能导致肾单位数较少[128，129]，这导致在中老年后肾脏功能下降较快[130，131，132，133]；</p>
 <p data-pid="d7P5vcrM">早期营养不良的人也有更大的几率肥胖，肥胖导致的胰岛素抵抗也会减少尿酸排泄，从而间接促成高尿酸血症[138，139，140，141]。</p>
 <hr>
 <h2>八、久坐可能导致尿酸高</h2>
 <p data-pid="KQH3QKmR">在现代社会，一般人清醒的大部分时间都坐着，但久坐带来的问题是多方面的：</p>
 <ul>
  <li data-pid="Orit-MVY">在心血管疾病患者中，久坐是造成所有类型死亡的一个强力的独立因素[90]；</li>
  <li data-pid="mblKl5Cc">大量的体育活动可以防止体重增加，体育活动是预防肥胖的一个关键因素[91]；</li>
  <li data-pid="-woCIdOX">每天坐超过&gt;10小时的人，比坐&lt;1小时的，死亡率高出34%，久坐时间是一个影响健康的独立因素，无论是否肥胖[92]；</li>
  <li data-pid="qW75SI46"><b>更糟糕的是</b>，根据最近的研究，如果超过每日平均坐时间，定期运动所提供的积极健康结果就会消失，并可能导致慢性病的机会增加[93]；</li>
 </ul>
 <p data-pid="HoyGI07O">体力活动减少、久坐，也是升高尿酸的因素。一项我国的荟萃分析（包含11项研究，63689人）表明：低/中等强度体力活动会降低高尿酸风险：男性12%/女性1%；高强度体力活动降低高尿酸风险：男性29%/女性32%。</p>
 <figure data-size="normal">
  <img src="https://picx.zhimg.com/50/v2-f79924c7b83a04e68560828e6d135c6e_720w.jpg?source=1940ef5c" data-rawwidth="998" data-rawheight="818" data-size="normal" data-caption="" data-original-token="v2-f79924c7b83a04e68560828e6d135c6e" data-default-watermark-src="https://picx.zhimg.com/50/v2-c0128cabaf31b86cd221b754ceac2631_720w.jpg?source=1940ef5c" class="origin_image zh-lightbox-thumb" width="998" data-original="https://pica.zhimg.com/v2-f79924c7b83a04e68560828e6d135c6e_r.jpg?source=1940ef5c">
 </figure>
 <p data-pid="1k1XlW2b">其可能的机制是：</p>
 <p data-pid="9ac6N7Jy">胰岛素会促进钠在肾小管的吸收，从而减少尿酸的排放[95]，因此胰岛素抵抗/肥胖可能升高血尿酸水平[96，97]；久坐会减少能量消耗[100，101]，减少肌肉中的葡萄糖和脂肪使用，从而增加胰岛抵抗[102，103]；而肌肉收缩、体力活动可以减少胰岛素抵抗[98]，运动本身也可以减少尿酸的生成[96，99]。</p>
 <hr>
 <h2>九、番茄可能升高尿酸</h2>
 <p data-pid="qTCnWagp">很多人容易忽视番茄，以为番茄是低嘌呤食物，可以多吃。番茄一直以来就被各地的报告容易造成痛风。在一些报道中，番茄被痛风患者提到容易触发痛风，需要避免[105]；在新西兰的痛风人群中，番茄摄入与痛风发作频率正相关[106]；</p>
 <p data-pid="sR48JnyX">LEE等人发现吃了番茄酱后尿酸水平升高[107]；tanya等人研究确诊痛风的2051名毛利人发现，<b>番茄摄入量确实与尿酸水平正相关</b>[110]。</p>
 <figure data-size="normal">
  <img src="https://pic1.zhimg.com/50/v2-507e11fafbcab65a7dc8e8353b0d55f1_720w.jpg?source=1940ef5c" data-rawwidth="1269" data-rawheight="386" data-size="normal" data-caption="" data-original-token="v2-507e11fafbcab65a7dc8e8353b0d55f1" data-default-watermark-src="https://picx.zhimg.com/50/v2-9220a185f9f88b5b60fd25458dede38f_720w.jpg?source=1940ef5c" class="origin_image zh-lightbox-thumb" width="1269" data-original="https://picx.zhimg.com/v2-507e11fafbcab65a7dc8e8353b0d55f1_r.jpg?source=1940ef5c">
 </figure>
 <p data-pid="CtXEXXGf">作者提出的解释是：</p>
 <p data-pid="Aqt45EOY">（1）虽然番茄本身的嘌呤含量的确很低[108]，但番茄中含有较高多的谷氨酸，能在人体嘌呤合成途径中充当氮的供应者，来刺激或放大尿酸的合成[108，109]；</p>
 <p data-pid="CQk8iBpo">（2）番茄中含有一些化合物（p-coumaric acid、ferullic acid、p-hydroxybenzoic acid 、vanillic acid），这些化合物可以与OAT1、OAT3等肾脏中参与尿酸代谢的转运蛋白相互作用，从而影响肾脏对尿酸的排泄。</p>
 <p data-pid="MkMa69DU">对于这一点，痛风或者高尿酸的朋友可以特别注意，否则可能尿酸高了还不知道为什么。</p>
 <hr>
 <h2>十、如果操作得当，高尿酸的人或许能进行力量训练和采取高蛋白饮食</h2>
 <p data-pid="Ld1pTMYp">众所周知，尿酸高的人一般不能做无氧运动，而且吃高蛋白健身饮食也可能会导致尿酸升高，所以很多尿酸高的人都是停练状态。</p>
 <p data-pid="gr2MaNBT">我有一个学生是遗传性高尿酸，500-530，但是不想放弃力量和肌肉。在他的强烈要求下，我尝试性的给他进行了饮食和训练调整，没想到他的尿酸水平从530降低到了现在的350不到。</p>
 <p data-pid="ZnBhjCXg">而且更可喜的是，这是在没有使用任何降尿酸的药物前提下实现的。</p>
 <p data-pid="8glu0rs5">我不敢保证这样的效果能在所有人身上复制，但是至少给了高尿酸的人一种希望，在饮食和计划安排得当的前提下，他们也有可能继续保持力量训练。</p>
 <figure data-size="normal">
  <img src="https://picx.zhimg.com/50/v2-41512a106a5db719ef9733946313eb46_720w.jpg?source=1940ef5c" data-rawwidth="2124" data-rawheight="2012" data-size="normal" data-original-token="v2-8d957b839a8829203e5a26e8cc55ac33" data-default-watermark-src="https://picx.zhimg.com/50/v2-52d4e9402837db8bf2e73583ebfa85f9_720w.jpg?source=1940ef5c" class="origin_image zh-lightbox-thumb" width="2124" data-original="https://pic1.zhimg.com/v2-41512a106a5db719ef9733946313eb46_r.jpg?source=1940ef5c">
  <figcaption>
   学员反馈，尿酸降到347
  </figcaption>
 </figure>
 <figure data-size="normal">
  <img src="https://pic1.zhimg.com/50/v2-7bc4707c82486cef1a04106c50718307_720w.jpg?source=1940ef5c" data-rawwidth="2156" data-rawheight="1804" data-size="normal" data-original-token="v2-152a84b3becb746c04ec48d65f383c34" data-default-watermark-src="https://pic1.zhimg.com/50/v2-844e76fb2dbe5014c14fc92610b050bb_720w.jpg?source=1940ef5c" class="origin_image zh-lightbox-thumb" width="2156" data-original="https://picx.zhimg.com/v2-7bc4707c82486cef1a04106c50718307_r.jpg?source=1940ef5c">
  <figcaption>
   没吃药，而且去年夏天尿酸是500-530
  </figcaption>
 </figure>
 <hr>
 <h2>推荐阅读：</h2>
 <p data-pid="LJXi89QP"><a href="https://zhuanlan.zhihu.com/p/356859057" class="internal">肉崽：力训研究所课程介绍</a></p>
 <h2>健身5/6分化训练根本不适合普通人</h2>
 <p data-pid="OMrXgJS0"><a href="https://zhuanlan.zhihu.com/p/359118475" class="internal">肉崽：力训研究所新手指南（十二）为什么分化训练不适合普通人（上）</a></p>
 <p data-pid="uPKNiyFA"><a href="https://zhuanlan.zhihu.com/p/359220533" class="internal">肉崽：力训研究所新手指南（十三）为什么分化训练不适合普通人（中）</a></p>
 <p data-pid="9vWe79QC"><a href="https://zhuanlan.zhihu.com/p/359509585" class="internal">肉崽：力训研究所新手指南（十四）为什么分化训练不适合普通人（下）</a></p>
 <p class="ztext-empty-paragraph"><br></p>
 <h2>新手卧推用手臂？老手才能用胸发力？卧推要感受胸肌才有效？假的</h2>
 <p data-pid="sNlb28W0"><a href="https://zhuanlan.zhihu.com/p/145033293" class="internal">肉崽：卧推不需要感受胸肌或专注于胸肌收缩</a></p>
 <p data-pid="7gTRrjAn"><a href="https://www.zhihu.com/question/386864774/answer/1274853674" class="internal">怎么找到哑铃划船背阔肌发力感?</a></p>
 <p data-pid="GdtS6Hy-"><a href="https://www.zhihu.com/question/343071593/answer/1935804033" class="internal">练胸肌的时候，手臂力量经常跟不上怎么办?</a></p>
 <p class="ztext-empty-paragraph"><br></p>
 <h2>训练后不拉伸，没有任何问题</h2>
 <p data-pid="NttePlAB"><a href="https://zhuanlan.zhihu.com/p/347118770" class="internal">肉崽：训练后需要拉伸吗？（一）</a></p>
 <p data-pid="sWdhwsGQ"><a href="https://zhuanlan.zhihu.com/p/347124431" class="internal">肉崽：训练后需要拉伸吗？（二）</a></p>
 <p data-pid="_YDi3G3O"><a href="https://zhuanlan.zhihu.com/p/347128342" class="internal">肉崽：训练后需要拉伸吗？（三）</a></p>
 <p data-pid="4ZiS0Xuh"><a href="https://zhuanlan.zhihu.com/p/347133824" class="internal">肉崽：训练后需要拉伸吗：参考文献（1-200）</a></p>
 <p data-pid="yi3erQM4"><a href="https://zhuanlan.zhihu.com/p/347134571" class="internal">肉崽：训练后需要拉伸吗：参考文献（200-323）</a></p>
 <p class="ztext-empty-paragraph"><br></p>
 <h2>健美训练中被人误解的几大要素</h2>
 <p data-pid="-ZHsyuZ7"><a href="https://zhuanlan.zhihu.com/p/362378824" class="internal">肉崽：被误解最多的健美训练要素（一）：轻重量精确刺激肌肉</a></p>
 <p data-pid="ui_Flp95"><a href="https://zhuanlan.zhihu.com/p/366883112" class="internal">肉崽：被误解最多的健美训练要素（二）：慢速动作</a></p>
 <p data-pid="MFeu6JHH"><a href="https://zhuanlan.zhihu.com/p/368500332" class="internal">肉崽：被误解最多的健美训练要素（三）：孤立训练</a></p>
 <p data-pid="03ju0ib7"><a href="https://zhuanlan.zhihu.com/p/369934141" class="internal">肉崽：被误解最多的健美训练要素（四）：变换动作给予肌肉新刺激</a></p>
 <p data-pid="6doDfDGR"><a href="https://zhuanlan.zhihu.com/p/369561213" class="internal">肉崽：被误解最多的健美训练要素（五）：依据肌纤维类型针对训练</a></p>
 <p data-pid="oRTcehSZ"><a href="https://zhuanlan.zhihu.com/p/359358634" class="internal">肉崽：“8-12次最佳增肌次数范围” 其实是个伪命题</a></p>
 <p class="ztext-empty-paragraph"><br></p>
 <h2>动作细节=技术？细节不同天翻地覆？纯属瞎掰。</h2>
 <p data-pid="Fbu0MPQR"><a href="https://zhuanlan.zhihu.com/p/348201155" class="internal">肉崽：动作细节的影响有多大？</a></p>
 <p class="ztext-empty-paragraph"><br></p>
 <h2>飞鸟和夹胸练中缝，纯属虚构</h2>
 <p data-pid="LI82BkQu"><a href="https://zhuanlan.zhihu.com/p/141386724" class="internal">肉崽：胸肌中缝和铠甲胸是飞鸟练出来的吗？</a></p>
 <p class="ztext-empty-paragraph"><br></p>
 <h2>练胸不练背，既不会改变体态，也不会“圆肩”</h2>
 <p data-pid="scdVljxX"><a href="https://zhuanlan.zhihu.com/p/143307529" class="internal">肉崽：练胸不练背会圆肩？有多少人上当受骗？</a></p>
 <p class="ztext-empty-paragraph"><br></p>
 <h2>并不是训练让我们变强，而是训练激发了、挖掘了你本身就有的潜力。</h2>
 <p data-pid="e_tdDkUk"><a href="https://www.zhihu.com/question/29764861/answer/1614974408" class="internal">那些健身模特是不是都在用类固醇？普通人能不能练成这样？</a></p>
 <p class="ztext-empty-paragraph"><br></p>
 <h2>训练增肌的核心原理，并不是“练得微损伤后修复增粗”</h2>
 <p data-pid="c2vo7zB8"><a href="https://zhuanlan.zhihu.com/p/355476297" class="internal">肉崽：力训研究所新手指南（八）增肌的深层原理</a></p>
 <p class="ztext-empty-paragraph"><br></p>
 <h2>激素的增肌原理，其实跟训练是一样的</h2>
 <p data-pid="Jit78f04"><a href="https://www.zhihu.com/question/349185338/answer/1959357182" class="internal">既然只有蛋白质才能转化肌肉为什么增肌期间还要摄入大量碳水？</a></p>
 <p data-pid="5DqgriYh"><a href="https://www.zhihu.com/question/435024908/answer/1629604403" class="internal">生长激素到底能够增加肌纤维数量吗？</a></p>
 <p class="ztext-empty-paragraph"><br></p>
 <h2>营养具有跟训练、激素类似的增肌作用</h2>
 <p data-pid="pEe1ei6x"><a href="https://www.zhihu.com/question/398517719/answer/1955319169" class="internal">为什么减脂容易掉肌肉?</a></p>
 <p data-pid="9ouI15TY"><a href="https://www.zhihu.com/question/347452295/answer/1920571151" class="internal">不健身直接吃蛋白粉会怎么样？</a></p>
 <p data-pid="dTl47W7J"><a href="https://www.zhihu.com/question/304946729/answer/1926437836" class="internal">健身练到那种程度可以开始喝蛋白粉？</a></p>
 <p class="ztext-empty-paragraph"><br></p>
 <h2>人人都在说蛋白质过量，但其实很难实现</h2>
 <p data-pid="aucwxr2_"><a href="https://www.zhihu.com/question/422316054/answer/1929989864" class="internal">蛋白质摄入过多的危害有哪些？</a></p>
 <p data-pid="V9nLryQv"><a href="https://www.zhihu.com/question/28463251/answer/1933985697" class="internal">健身一定要喝蛋白粉吗，还有健身危害比如说对肝脏？</a></p>
 <p data-pid="YM-CxWdL"><a href="https://zhuanlan.zhihu.com/p/358760499" class="internal">肉崽：聊聊补剂商人自己都不知道的左旋肉碱用处</a></p>
 <p class="ztext-empty-paragraph"><br></p>
 <h2>高训练量是个坑，而且是大坑</h2>
 <p data-pid="sN3fU36-"><a href="https://zhuanlan.zhihu.com/p/375576490" class="internal">肉崽：堆训练量？3倍努力，事倍功半</a></p>
 <p data-pid="Me2BO2Ai"><a href="https://zhuanlan.zhihu.com/p/372723969" class="internal">肉崽：从一个高容量计划换成另一个高容量计划，为什么进步了？</a></p>
 <p data-pid="lA_0OYNO"><a href="https://zhuanlan.zhihu.com/p/369039152" class="internal">肉崽：10X10改良版数据带给我们的启示</a></p>
 <p class="ztext-empty-paragraph"><br></p>
 <h2>同样的训练，有些人比别人增肌幅度大好几倍，不是因为技术差异</h2>
 <p data-pid="ssTa8D3R"><a href="https://zhuanlan.zhihu.com/p/340481124" class="internal">肉崽：训练潜力与遗传（一）：蛋白质与基因</a></p>
 <p data-pid="uXzpdEjs"><a href="https://zhuanlan.zhihu.com/p/341264333" class="internal">肉崽：训练潜力与遗传（二）：DNA的表达</a></p>
 <p data-pid="OnPYe13A"><a href="https://zhuanlan.zhihu.com/p/342601722" class="internal">肉崽：训练潜力与遗传（三）：肌肉水平与细胞核</a></p>
 <p data-pid="7kmB0AIz"><a href="https://zhuanlan.zhihu.com/p/350931084" class="internal">肉崽：训练潜力与遗传（四）：肌肉水平与微RNA</a></p>
 <p data-pid="F8yolDrp"><a href="https://zhuanlan.zhihu.com/p/373290377" class="internal">肉崽：训练潜力与遗传（五）：肌肉增长与睾酮受体</a></p>
 <p class="ztext-empty-paragraph"><br></p>
 <h2>对于同一个训练体系来说，肌肉和力量成正比</h2>
 <p data-pid="0BaCrFZo"><a href="https://zhuanlan.zhihu.com/p/350831442" class="internal">肉崽：力量举的“天赋”主要指什么？</a></p>
 <p class="ztext-empty-paragraph"><br></p>
 <h2>睡眠从分子角度如何影响肌肉的代谢</h2>
 <p data-pid="FXwTCVpS"><a href="https://www.zhihu.com/question/44055485/answer/1992536661" class="internal">“肌肉在休息的时候超量生长”，其中关于“休息”的定义是睡觉吗？</a></p>
 <p data-pid="WfPvX853"><a href="https://www.zhihu.com/question/424764347/answer/1988922739" class="internal">如果你每天睡眠时间只有6个小时，你是否愿意拿出半个小时锻炼身体？</a></p>
 <p data-pid="wBzcJMBD"><a href="https://www.zhihu.com/question/469054853/answer/1986670064" class="internal">为何一天1小时的力量+高强度无氧+1小时有氧跑，已坚持近半个月既没减脂又没增肌？</a></p>
 <p data-pid="WGA1MHTR"><a href="https://zhuanlan.zhihu.com/p/392265928" class="internal">肉崽：健身与睡眠（三）</a></p>
 <p class="ztext-empty-paragraph"><br></p>
 <h2>生酮饮食的效果与高碳饮食的减肥效果差异很小</h2>
 <p data-pid="HNHyUyOp"><a href="https://zhuanlan.zhihu.com/p/358659907" class="internal">肉崽：生酮饮食（一）：效果</a></p>
 <p data-pid="pKRCo3sY"><a href="https://zhuanlan.zhihu.com/p/137818940" class="internal">肉崽：低碳生酮饮食（五）副作用：概况和死亡风险</a></p>
 <p data-pid="7yzXgiMK"><a href="https://zhuanlan.zhihu.com/p/137865950" class="internal">肉崽：低碳生酮饮食（七）副作用：肝损伤</a></p>
 <p data-pid="4QS05ShF"><a href="https://zhuanlan.zhihu.com/p/137915615" class="internal">肉崽：低碳生酮饮食（八）副作用：骨健康</a></p>
 <p data-pid="CrBYM3H_"><a href="https://zhuanlan.zhihu.com/p/137987392" class="internal">肉崽：低碳生酮饮食（九）副作用：骨健康</a></p>
 <p data-pid="hQXj2VEq"><a href="https://zhuanlan.zhihu.com/p/138818987" class="internal">肉崽：低碳生酮饮食（十一）肾结石和胆结石</a></p>
 <p data-pid="VmG7NvQX"><a href="https://zhuanlan.zhihu.com/p/358032414" class="internal">肉崽：生酮饮食是如何损害心脏的？（上）</a></p>
 <p data-pid="H4-9hL4a"><a href="https://zhuanlan.zhihu.com/p/358035982" class="internal">肉崽：生酮饮食是如何损害心脏的？（下）</a></p>
 <p class="ztext-empty-paragraph"><br></p>
 <h2>个人实践没有任何说服力，“干就完了”“练得大说得对”都属于缺乏基本的逻辑和常识</h2>
 <p data-pid="OCFIa5fe"><a href="https://zhuanlan.zhihu.com/p/138963959" class="internal">肉崽：健身爱好者最大的误区之一：“实践出真知”</a></p>
 <p data-pid="zmZ9HJeH"><a href="https://zhuanlan.zhihu.com/p/355454805" class="internal">肉崽：力咖新手指南（六）新手必须避开的认知雷区：（上）</a></p>
 <p data-pid="DswCmd0Z"><a href="https://zhuanlan.zhihu.com/p/355459705" class="internal">肉崽：力咖新手指南（六）新手必须避开的认知雷区：（中）</a></p>
 <p class="ztext-empty-paragraph"><br></p>
 <h2>营养/恢复相关</h2>
 <p data-pid="vhxde6PT"><a href="https://www.zhihu.com/question/347452295/answer/1920571151" class="internal">不健身直接吃蛋白粉会怎么样？</a></p>
 <p data-pid="WHa8nEFi"><a href="https://www.zhihu.com/question/314242661/answer/1949634820" class="internal">健身一年没有什么进步，正常吗？</a></p>
 <p data-pid="ZYS9kLqw"><a href="https://www.zhihu.com/question/398517719/answer/1955319169" class="internal">为什么减脂容易掉肌肉?</a></p>
 <p data-pid="F_PSLZI9"><a href="https://www.zhihu.com/question/349185338/answer/1959357182" class="internal">既然只有蛋白质才能转化肌肉为什么增肌期间还要摄入大量碳水？</a></p>
 <p data-pid="sVCoQpkX"><a href="https://www.zhihu.com/question/469054853/answer/1986670064" class="internal">为何一天1小时的力量+高强度无氧+1小时有氧跑，已坚持近半个月既没减脂又没增肌？</a></p>
 <p data-pid="EH_JOWYh"><a href="https://www.zhihu.com/question/332444954/answer/2041890798" class="internal">为什么都说增肌要碳水？</a></p>
 <p data-pid="y13gIsnc"><a href="https://www.zhihu.com/question/451814736/answer/2056309917" class="internal">当代年轻人为什么尿酸会高？</a></p>
 <p data-pid="rzqQpmKv"><a href="https://www.zhihu.com/question/21859614/answer/2086229793" class="internal">肌酸跟蛋白粉到底对肾脏有没有影响？</a></p>
 <hr>
 <h2>References</h2>
 <p data-pid="2Hh9UKMH">1. Oda M, Satta Y, Takenaka O, Takahata N. Loss of urate oxidase activity in hominoids and its evolutionary implications. Mol Biol Evol. 2002;19(5):640–653.</p>
 <p data-pid="jtcCb3Pk">2. Masako Oda, Yoko Satta, Osamu Takenaka, Naoyuki Takahata.Loss of urate oxidase activity in hominoids and its evolutionary implications.Mol Biol Evol. 2002 May;19(5):640-53.</p>
 <p data-pid="kgyO8ej1">3. Ackerman Z., Oron-Herman M., Grozovski M., Rosenthal T., Pappo O., Link G., and Sela B. A. (2005) Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction. Hypertension 45, 1012–1018.</p>
 <p data-pid="UkGh9eo6">4. Ishimoto T., Lanaspa M. A., Le M. T., Garcia G. E., Diggle C. P., Maclean P. S., Jackman M. R., Asipu A., Roncal-Jimenez C. A., Kosugi T., Rivard C. J., Maruyama S., Rodriguez-Iturbe B., Sánchez-Lozada L. G., Bonthron D. T., et al. (2012) Opposing effects of fructokinase C and A isoforms on fructose-induced metabolic syndrome in mice. Proc. Natl. Acad. Sci. U.S.A. 109, 4320–4325</p>
 <p data-pid="OnyAzIhN">5. Lanaspa M. A., Sanchez-Lozada L. G., Choi Y. J., Cicerchi C., Kanbay M., Roncal-Jimenez C. A., Ishimoto T., Li N., Marek G., Duranay M., Schreiner G., Rodriguez-Iturbe B., Nakagawa T., Kang D. H., Sautin Y. Y., et al. (2012) Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver. J. Biol. Chem. 287, 40732–40744</p>
 <p data-pid="Hmw5Dvh4">6. Lanaspa M. A., Cicerchi C., Garcia G., Li N., Roncal-Jimenez C. A., Rivard C. J., Hunter B., Andrés-Hernando A., Ishimoto T., Sánchez-Lozada L. G., Thomas J., Hodges R. S., Mant C. T., and Johnson R. J. (2012) Counteracting roles of AMP deaminase and AMP kinase in the development of fatty liver. PLoS One 7.</p>
 <p data-pid="WNDa_9FF">7. Tana C., Ticinesi A., Prati B., Nouvenne A., Meschi T. (2018). Uric Acid and Cognitive Function in Older Individuals. Nutrients 10, 97</p>
 <p data-pid="9WwEOrjs">8. Kimura T., Takahashi M., Yan K., Sakurai H. (2014). Expression of SLC2A9 Isoforms in the Kidney and Their Localization in Polarized Epithelial Cells. PLoS One 9, e84996.</p>
 <p data-pid="ZjIq9tNb">9. Laura G. Sanchez-Lozada1 , Ana Andres-Hernando2 , Fernando E. Garcia-Arroyo1 , Christina Cicerchi2 , Nanxing Li2 , Masanari Kuwabara2 , Carlos A. Roncal-Jimenez2 , Richard J. Johnson2 and Miguel A. Lanaspa 2* . Uric acid</p>
 <p data-pid="vsHxYNYQ">activates aldose reductase and the polyol pathway for endogenous fructose and fat production causing development of fatty liver in rats.JBC Papers in Press. Published on January 16, 2019 as Manuscript RA118.006158.</p>
 <p data-pid="Hhtz_rpJ">10. Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension. 2003;41(6):1183–1190.</p>
 <p data-pid="wmVn5s7-">11. Mene P, Punzo G. Uric acid: bystander or culprit in hypertension and progressive renal disease? Journal of Hypertension. 2008;26(11):2085–2092.</p>
 <p data-pid="KKfo_PYo">12. Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, et al. Hyperuricemia induces endothelial dysfunction. Kidney International. 2005;67(5):1739–1742.</p>
 <p data-pid="3HtHXgqI">13. Farquharson CA, Butler R, Hill A, Belch JJ, Struthers AD. Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation. 2002;106(2):221–226.</p>
 <p data-pid="Fj3o_2Nh">14. Doehner W, Schoene N, Rauchhaus M, Leyva-Leon F, Pavitt DV, Reaveley DA, et al. Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies. Circulation. 2002;105(22):2619–2624.</p>
 <p data-pid="mQPBnryM">15. Toma I, Kan J, Meer E, Pet-Peterdi J. Uric acid triggers renin release via a macula densa-dependent pathway. Presented at: American Society of Nephrology Annual Meeting; San Francisco, CA. 2007. F-P0240.</p>
 <p data-pid="a-W65W8E">16. Perlstein TS, Gumieniak O, Hopkins PN, Murphey LJ, Brown NJ, Williams GH, et al. Uric acid and the state of the intrarenal renin-angiotensin system in humans. Kidney International. 2004;66(4):1465–1470.</p>
 <p data-pid="65iNvO6C">17. S. E. Kocyigit, P. Soysal, E. Ates Bulut &amp; A. T. Isik.Malnutrition and Malnutrition Risk Can Be Associated with Systolic Orthostatic Hypotension in Older Adults.The journal of nutrition, health &amp; aging volume 22, pages 928–933 (2018).</p>
 <p data-pid="xvbyPJHH">18. Joel B Gunter.Fasting, halothane, and hypotension.Anesth Analg. 2003 May;96(5):1537-8; author reply 1538.</p>
 <p data-pid="FQuiQkaa">19. T D Williams 1 , J B Chambers, R P Henderson, M E Rashotte, J M Overton.Cardiovascular responses to caloric restriction and thermoneutrality in C57BL/6J <a href="https://link.zhihu.com/?target=http%3A//mice.am/" class=" wrap external" target="_blank" rel="nofollow noreferrer">mice.Am</a> J Physiol Regul Integr Comp Physiol. 2002 May;282(5):R1459-67.</p>
 <p data-pid="a8n5IKkl">20. B N Ames, R Cathcart, E Schwiers, and P Hochstein.Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis.Proc Natl Acad Sci U S A. 1981 Nov; 78(11): 6858–6862.</p>
 <p data-pid="DncHCZS2">21. Masako Oda, Yoko Satta, Osamu Takenaka, Naoyuki Takahata.Loss of urate oxidase activity in hominoids and its evolutionary implications.Mol Biol Evol. 2002 May;19(5):640-53.</p>
 <p data-pid="FMVrox52">22. Fatemeh Dabbagh, Mohammad B Ghoshoon, Shiva Hemmati, Mozhdeh Zamani, Milad Mohkam, Younes <a href="https://link.zhihu.com/?target=http%3A//ghasemi.engineering/" class=" wrap external" target="_blank" rel="nofollow noreferrer">Ghasemi.Engineering</a> Human Urate Oxidase: Towards Reactivating It as an Important Therapeutic Enzyme.Curr Pharm Biotechnol.2015;17(2):141-6.</p>
 <p data-pid="kCPzKoV0">23. Jessica Maiuolo, Francesca Oppedisano, Santo Gratteri, Carolina Muscoli, Vincenzo Mollace.Regulation of uric acid metabolism and <a href="https://link.zhihu.com/?target=http%3A//excretion.int/" class=" wrap external" target="_blank" rel="nofollow noreferrer">excretion.Int</a> J Cardiol. 2016 Jun 15;213:8-14.</p>
 <p data-pid="xG17mH0p">24. Jessica Maiuolo, Gratteri S, Muscoli C, Mollace V.(2016). Regulation of Uric Acid Metabolism and Excretion. Int.J.Cardiol.15,8–14.</p>
 <p data-pid="99a8JdUJ">25. Nieto C. I. F. J., Gross M. D., Comstock G. W., Cutler R. G. (2000). Uric Acid and Serum Antioxidant Capacity: a Reaction to Atherosclerosis? Atherosclerosis 148, 131–139.</p>
 <p data-pid="PSPZy8Ya">26. Wang Q., Wen X., Kong J. (2020). Recent Progress on Uric Acid Detection: A Review. Crit. Rev. Anal Chem. 50, 359–375.</p>
 <p data-pid="iGX91B50">27. Bassanese G., Wlodkowski T., Servais A., Heidet L., Roccatello D., Emma F., et al. (2021). The European Rare Kidney Disease Registry (ERKReg): Objectives, Design and Initial Results. Orphanet J. Rare Dis. 16, 251.</p>
 <p data-pid="TJ4p86n_">28. So A., Thorens B. (2010). Uric Acid Transport and Disease. J. Clin. Invest 120, 1791–1799.</p>
 <p data-pid="Os9U0uI_">29. Bardin T., Richette P. (2014). Definition of Hyperuricemia and Gouty Conditions. Curr. Opin. Rheumatol. 26, 186–191.</p>
 <p data-pid="CI95Fpo-">30. Latourte, Augustina,b; Bardin, Thomasa,b; Richette, Pascala,b.Uric acid and cognitive decline: a double-edge sword?.Current Opinion in Rheumatology: March 2018 - Volume 30 - Issue 2 - p 183-187.</p>
 <p data-pid="NLgfpyrD">31. Ebert K., Ludwig M., Geillinger K. E., Schoberth G. C., Essenwanger J., Stolz J., et al. (2017). Reassessment of GLUT7 and GLUT9 as Putative Fructose and Glucose Transporters. J. Membr. Biol. 250, 171–182.</p>
 <p data-pid="L2m4f-Qu">32. Akaoka I, Nishizawa T, Yano E, Takeuchi A, Nishida Y. Familial hypouricaemia due to renal tubular defect of urate transport. Ann Clin Res. 1975;7(5):318–324.</p>
 <p data-pid="Ups5fgI7">33. Wakasugi M, Kazama JJ, Narita I, Konta T, Fujimoto S, Iseki K, et al. Association between hypouricemia and reduced kidney function: a cross-sectional population-based study in Japan. Am J Nephrol. 2015;41(2):138–146.</p>
 <p data-pid="48gOmHnj">34. Suzuki T, Kidoguchi K, Hayashi A. Genetic heterogeneity of familial hypouricemia due to isolated renal tubular defect. Jinrui Idengaku Zasshi. 1981;26(3):243–248.</p>
 <p data-pid="WiJgtpAC">35. Kikuchi Y., Koga H., Yasutomo Y., Kawabata Y., Shimizu E., Naruse M., Kiyama S., Nonoguchi H., Tomita K., Sasatomi Y. Patients with renal hypouricemia with exercise-induced acute renal failure and chronic renal dysfunction. Clin. Nephrol. 2000;53:467–472.</p>
 <p data-pid="XdmP7w3b">36. Diamond H.S., Paolino J.S. Evidence for a postsecretory reabsorptive site for uric acid in man. J. Clin. Invest. 1973;52:1491–1499.</p>
 <p data-pid="Z3pkengX">37. Hosoyamada M., Ichida K., Enomoto A., Hosoya T., Endou H. (2004). Function and Localization of Urate Transporter 1 in Mouse Kidney. J. Am. Soc. Nephrol. 15, 261–268.</p>
 <p data-pid="MHK6405e">38. Enomoto A., Kimura H., Chairoungdua A., Shigeta Y., Jutabha P., Cha S. H., et al. (2002). Molecular Identification of a Renal Urate Anion Exchanger that Regulates Blood Urate Levels. Nature 417, 447–452.</p>
 <p data-pid="BFGItvbc">39. Zhou F., Zhu L., Cui P. H., Church W. B., Murray M. (2010). Functional Characterization of Nonsynonymous Single Nucleotide Polymorphisms in the Human Organic Anion Transporter 4 (hOAT4). Br. J Pharmacol 159, 419–427.</p>
 <p data-pid="MQTIy7HZ">40. Skwara P., Sch?mig E., Gründemann D. (2017). A Novel Mode of Operation of SLC22A11: Membrane Insertion of Estrone Sulfate versus Translocation of Uric Acid and Glutamate. Biochem. Pharmacol. 15, 74–82.</p>
 <p data-pid="-gTMUmZC">41. Zhu C., Sun Bao., Zhang B., Zhou Z. (2021). An Update of Genetics, Co-morbidities and Management of Hyperuricemia. Clin. Exp. Pharmacol. Physiol.</p>
 <p data-pid="ETQBd3E_">42. Pasquale Strazzullo, Juan Garcia Puig.Uric acid and oxidative stress: relative impact on cardiovascular risk?.Nutr Metab Cardiovasc Dis. 2007 Jul;17(6):409-14.</p>
 <p data-pid="gvF4ke9b">43. Mandal A. K., Mount D. B. (2019). Interaction between ITM2B and GLUT9 Links Urate Transport to Neurodegenerative Disorders.</p>
 <p data-pid="qw_EFbXX">44. Ascherio A., LeWitt P. A., Xu K., Eberly S., Watts A., Matson W. R., et al. (2009). Urate as a Predictor of the Rate of Clinical Decline in Parkinson Disease. Randomized Controlled Trial 66, 1460–1468.</p>
 <p data-pid="OM6qNwMc">45. Du N., Xu D., Hou X., Song X., Liu C., Chen Y., et al. (2016). Inverse Association between Serum Uric Acid Levels and Alzheimer's Disease Risk. Mol. Neurobiol. 53, 2594–2599.</p>
 <p data-pid="5iIOPlnj">46. Ye B. S., Lee W. W., Ham J. H., Lee J. J., Lee P. H., Sohn Y. H. (2016). Does Serum Uric Acid Act as a Modulator of Cerebrospinal Fluid Alzheimer's Disease Biomarker Related Cognitive Decline? Eur. J. Neurol. 23, 948–957.</p>
 <p data-pid="empg6IVY">47. Cunningham R., Brazie M., Kanumuru S., Xiaofei E., Biswas R., Wang F., et al. (2007). Sodium-hydrogen Exchanger Regulatory Factor-1 Interacts with Mouse Urate Transporter 1 to Regulate Renal Proximal Tubule Uric Acid Transport. J. Am. Soc. Nephrol. 18, 1419–1425.</p>
 <p data-pid="6sx2cWRe">48. Shenolikar S., Voltz J. W., Minkoff C. M., Wade J. B., Weinman E. J. (2002). Targeted Disruption of the Mouse NHERF-1 Gene Promotes Internalization of Proximal Tubule Sodium-Phosphate Cotransporter Type IIa and Renal Phosphate Wasting. Proc. Natl. Acad. Sci. U S A. 99, 11470–11475.</p>
 <p data-pid="xyiX0J8X">49. Houlihan L. M., Wyatt N. D., Harris S. E., Hayward C., Gow A. J., Marioni R. E., et al. (2010). Variation in the Uric Acid Transporter Gene (SLC2A9) and Memory Performance. Hum. Mol. Genet. 19, 2321–2330.</p>
 <p data-pid="V8vdsa7F">50. Maliepaard M., Scheffer G. L., Faneyte I. F., van Gastelen M. A., Pijnenborg A. C., Schinkel A. H., et al. (2001). Subcellular Localization and Distribution of the Breast Cancer Resistance Protein Transporter in Normal Human Tissues. Cancer Res. 61, 3458–3464.</p>
 <p data-pid="cGSOKkHT">51. Yun-Hong Lu Y.-P. C., Li T., Han F., Li C-J., Li X-Y., Xue M., et al. (2020). Empagliflozin Attenuates Hyperuricemia by Upregulation of ABCG2 via AMPK/AKT/CREB Signaling Pathway in Type 2 Diabetic Mice. Int. J. Biol. Sci. 16, 529–542.</p>
 <p data-pid="vTqfA86p">52. Matsuo H., Takada T., Ichida K., Nakamura T., Nakayama A., Ikebuchi Y., et al. (2009). Common Defects of ABCG2, a High-Capacity Urate Exporter, Cause Gout: A Function-Based Genetic Analysis in a Japanese Population. Sci. Transl Med. 1, 5ra11.</p>
 <p data-pid="U8vMjmZ3">53. Ichida K., Matsuo H., Takada T., Nakayama A., Murakami K., Shimizu T., et al. (2012). Decreased Extra-renal Urate Excretion Is a Common Cause of Hyperuricemia. Nat. Commun. 3, 764.</p>
 <p data-pid="V8fLjd6X">54. Yano H., Tamura Y., Kobayashi K., Tanemoto M., Uchida S. (2014). Uric Acid Transporter ABCG2 Is Increased in the Intestine of the 5/6 Nephrectomy Rat Model of Chronic Kidney Disease. Clin. Exp. Nephrol. 18, 50–55.</p>
 <p data-pid="GskghfzW">55. Nigam S. K. (2015). What Do Drug Transporters Really Do? Nat. Rev. Drug Discov. 14, 29–44.</p>
 <p data-pid="mRwIMCXT">56. Bhatnagar V., Richard E. L., Wu W., Nievergelt C. M., Lipkowitz M. S., Jeff J., et al. (2016). Analysis of ABCG2 and Other Urate Transporters in Uric Acid Homeostasis in Chronic Kidney Disease: Potential Role of Remote Sensing and Signaling. Clin. Kideny J. 9, 444–453.</p>
 <p data-pid="fEtJL1Hp">57. Cleophas M. C., Joosten L. A., Stamp L. K., Dalbeth N., Woodward O. M., Merriman T. R. (2017). ABCG2 Polymorphisms in Gout: Insights into Disease Susceptibility and Treatment Approaches. Pharmgenomics Pers Med. 10, 129–142.</p>
 <p data-pid="3r1E6VuR">58. Nigam S. K., Bhatnagar V. (2018). The Systems Biology of Uric Acid Transporters: the Role of Remote Sensing and Signaling. Curr. Opin. Nephrol. Hypertens. 27, 305–313.</p>
 <p data-pid="OoIt1tgY">59. Sorensen L. B. Role of the intestinal tract in the elimination of uric acid. Arthritis Rheum. 8, 694–706 (1965).</p>
 <p data-pid="rKTyucPq">60. Sica D. A. &amp; Schoolwerth A. in Brenner and Rector's The Kidney (ed. B.M. Brenner) 645–649 (Saunders, 2004).</p>
 <p data-pid="SU1rbcFe">61. Enomoto A. et al.. Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 417, 447–452 (2002).</p>
 <p data-pid="sic7uGzW">62. Li S. et al.. The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts. PLoS Genet. 3, e194 (2007).</p>
 <p data-pid="IIULVO-A">63. D?ring A. et al.. SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nat. Genet. 40, 430–436 (2008).</p>
 <p data-pid="ZlnGTWBt">64. Vitart V. et al.. SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat. Genet. 40, 437–442 (2008).</p>
 <p data-pid="9wAsfT27">65. Anzai N. et al.. Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans. J. Biol. Chem. 283, 26834–26838 (2008).</p>
 <p data-pid="-dX5iCfM">66. Dehghan A. et al.. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet 372, 1953–1961 (2008).</p>
 <p data-pid="41MLRLEO">67. Kolz M. et al.. Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet. 5, e1000504 (2009).</p>
 <p data-pid="mvXRA8dU">68. Kamatani Y. et al.. Genome-wide association study of hematological and biochemical traits in a Japanese population. Nat. Genet. 42, 210–215 (2010).</p>
 <p data-pid="9Jjg1XS7">69. X. W. Wu, C. C. Lee, D. M. Muzny, C. T. Caskey, Urate oxidase: Primary structure and evolutionary implications. Proc. Natl. Acad. Sci. U.S.A. 86, 9412–9416 (1989).</p>
 <p data-pid="QDanMA2N">70. C. C. Lee, X. W. Wu, R. A. Gibbs, R. G. Cook, D. M. Muzny, C. T. Caskey, Generation of cDNA probes directed by amino acid sequence: Cloning of urate oxidase. Science 239, 1288–1291 (1988).</p>
 <p data-pid="ye9TJC4P">71. R. G. Cutler, Urate and ascorbate: Their possible roles as antioxidants in determining longevity of mammalian species. Arch. Gerontol. Geriatr. 3, 321–348 (1984).</p>
 <p data-pid="Sbp_g-0r">72. Robinson PC. Gout-an update of aetiology, genetics, co-morbidities and management. Maturitas. 2018;118:67–73.</p>
 <p data-pid="nZNsgic_">73. Wang H, Zhang H, Sun L, Guo W. Roles of hyperuricemia in metabolic syndrome and cardiac-kidney-vascular system diseases. Am J Transl Res. 2018;10:2749–2763.</p>
 <p data-pid="X5_0tXJJ">74. Roddy E, Choi HK. Epidemiology of gout. Rheum Dis Clin North Am. 2014;40:155–175.</p>
 <p data-pid="onql-_3V">75. Ni Q, Lu X, Chen C, Du H, Zhang R. Risk factors for the development of hyperuricemia: a STROBE-compliant cross-sectional and longitudinal study. Medicine (Baltimore) 2019;98:e17597.</p>
 <p data-pid="CQjg_Hp-">76. Chaudhary NS, Bridges SL Jr, Saag KG, Rahn EJ, Curtis JR, Gaffo A, Limdi NA, Levitan EB, Singh JA, Colantonio LD, Howard G, Cushman M, Flaherty ML, Judd S, Irvin MR, Reynolds RJ. Severity of hypertension mediates the association of hyperuricemia with stroke in the REGARDS case cohort study. Hypertension. 2020;75:246–256.</p>
 <p data-pid="RBs379D7">77. Steiger S, Ma Q, Anders HJ. The case for evidence-based medicine for the association between hyperuricaemia and CKD. Nat Rev Nephrol. 2020;16:422.</p>
 <p data-pid="OSkq0vpm">78. Sato Y, Feig DI, Stack AG, Kang DH, Lanaspa MA, Ejaz AA, Sanchez-Lozada LG, Kuwabara M, Borghi C, Johnson RJ. The case for uric acid-lowering treatment in patients with hyperuricaemia and CKD. Nat Rev Nephrol. 2019;15:767–775.</p>
 <p data-pid="4JeF6WpG">79. Terkeltaub RA. Clinical practice. Gout. N Engl J Med. 2003;349:1647–1655.</p>
 <p data-pid="dLQZbTBb">80. Becker MA, Jolly M. In: Arthritis and Allied Conditions. 15. Koopman WJ, Moreland LW, editor. Philadelphia: Lippincott, Williams &amp; Wilkins; 2005. Clinical gout and the pathogenesis of hyperuricemia; pp. 2303–2339.</p>
 <p data-pid="MsSEnYJY">81. Wyngaarden JB, Kelley WN. Gout and Hyperuricemia. New York: Grune &amp; Stratton; 1976. pp. 1–512.</p>
 <p data-pid="SQ-FycJ_">82. Li T, Walsh JR, Ghishan FK, Bai L. Molecular cloning and characterization of a human urate transporter (hURAT1) gene promoter. Biochim Biophys Acta 2004; 1681:53–58.</p>
 <p data-pid="1LxnFB--">83. Fellstrom B., Danielson B.G., Karlstrom B., Lithell H., Ljunghall S., Vessby B. The influence of a high dietary intake of purine-rich animal protein on urinary urate excretion and supersaturation in renal stone disease. Clin. Sci. 1983;64:399–405.</p>
 <p data-pid="mWD9awAQ">84. Dalbeth N., Merriman T.R., Stamp L.K. Gout. Lancet. 2016;388:2039–2052.</p>
 <p data-pid="ZbkulDjM">85. Perez-Ruiz F., Calabozo M., Erauskin G.G., Ruibal A., Herrero-Beites A.M. Renal underexcretion of uric acid is present in patients with apparent high urinary uric acid output. Arthritis Rheum. 2002;47:610–613.</p>
 <p data-pid="D5WvrHm3">86. Qiong Yang, Chao-Yu Guo, L Adrienne Cupples, Daniel Levy, Peter W F Wilson, Caroline S Fox.Genome-wide search for genes affecting serum uric acid levels: the Framingham Heart Study.Metabolism. 2005 Nov;54(11):1435-41.</p>
 <p data-pid="HDt-WE_W">87. Juan García Puig 1 , María Angeles Martínez.Hyperuricemia, gout and the metabolic syndrome.Curr Opin Rheumatol. 2008 Mar;20(2):187-91.</p>
 <p data-pid="UPDT1xpc">88. Veronique Vitart et al.SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout.Nat Genet. 2008 Apr;40(4):437-42.</p>
 <p data-pid="Ygn1kKJn">89. Adrienne <a href="https://link.zhihu.com/?target=http%3A//tin.et/" class=" wrap external" target="_blank" rel="nofollow noreferrer">Tin.et</a> <a href="https://link.zhihu.com/?target=http%3A//al.target/" class=" wrap external" target="_blank" rel="nofollow noreferrer">al.Target</a> genes, variants, tissues and transcriptional pathways influencing human serum urate levels.Nat Genet. 2019 Oct; 51(10): 1459–1474.</p>
 <p data-pid="bYJ3xuqS">90. US Department of Health and Human Services. Physical Activity and Health: A Report of the Surgeon General. DIANE Publishing; 1996.</p>
 <p data-pid="39OTyvom">91. Katzmarzyk P, Janssen I, Ardern C. Physical inactivity, excess adiposity and premature mortality. Obesity Rev. 2003;4(4):257–290.</p>
 <p data-pid="TemKkqsP">92. Chau JY, Grunseit AC, Chey T, et al. Daily sitting time and all-cause mortality: a meta-analysis. PLoS One. 2013;8(11):e80000.</p>
 <p data-pid="_WefZxs_">93. Thyfault JP, Du M, Kraus WE, et al. Physiology of sedentary behavior and its relationship to health outcomes. Med Sci Sports Exerc. 2015;47(6):1301.</p>
 <p data-pid="6O6Iv0Tz">94. Yuan H, Yu C, Li X, et al. Serum uric acid levels and risk of metabolic syndrome: a dose-response meta-analysis of prospective studies. J Clin Endocrinol Metab. 2015;100(11):4198–4207.</p>
 <p data-pid="trmU_3mG">95. Facchini F, Chen Y-DI, Hollenbeck CB, Reaven GM. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. Jama. 1991;266(21):3008–3011.</p>
 <p data-pid="2e-dDZTf">96. Katzmarzyk P, Janssen I, Ardern C. Physical inactivity, excess adiposity and premature mortality. Obesity Rev. 2003;4(4):257–290.</p>
 <p data-pid="l9SfoAZF">97. Chau JY, Grunseit AC, Chey T, et al. Daily sitting time and all-cause mortality: a meta-analysis. PLoS One. 2013;8(11):e80000.</p>
 <p data-pid="XM6ieJ6w">98. Bouchard C, Blair SN, Katzmarzyk PT, et al. Less sitting, more physical activity, or higher fitness? Mayo Clinic Proc. 2015. Elsevier.</p>
 <p data-pid="ZQKp599u">99. Wannamethee SG, Shaper AG, Alberti KGM. Physical activity, metabolic factors, and the incidence of coronary heart disease and type 2 diabetes. Arch Intern Med. 2000;160(14):2108–2116.</p>
 <p data-pid="jK7mlPCz">100. Bey L, Hamilton MT. Suppression of skeletal muscle lipoprotein lipase activity during physical inactivity: a molecular reason to maintain daily low‐intensity activity. J Physiol. 2003;551(2):673–682.</p>
 <p data-pid="8VrRHQKM">101. Hamilton TM, Hamilton GD, Zderic WT. Exercise physiology versus inactivity physiology: an essential concept for understanding lipoprotein lipase regulation. Exerc Sport Sci Rev. 2004;32(4):161–166.</p>
 <p data-pid="C3Ctqdp_">102. Hu FB, Leitzmann MF, Stampfer MJ, et al. Physical activity and television watching in relation to risk for type 2 diabetes mellitus in men. (Original Investigation). Arch Internal Med. 2001;161(12):1542.</p>
 <p data-pid="v8Otuc_J">103. Hu F, Li T, Colditz G, Willett W, Manson JE. Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. JAMA. 2003;289(14):1785–1791.</p>
 <p data-pid="aocTK2zC">104. Lee I.R., Yang L., Sebetso G., Allen R., Doan T.H., Blundell R., Lui E.Y., Morrow C.A., Fraser J.A. Characterization of the complete uric acid degradation pathway in the fungal pathogen Cryptococcus neoformans. PLoS ONE. 2013;8:e64292.</p>
 <p data-pid="EDjJ0UIQ">105. Shulten P, Thomas J, Miller M, Smith M, Ahern M. The role of diet in the management of gout: a comparison of knowledge and attitudes to current evidence. J Hum Nutr Diet. 2009;22:3–11.</p>
 <p data-pid="crNy_OpJ">106. Winnard D, Wright C, Taylor WJ, Jackson G, Te Karu L, Arroll B, et al. National prevalence of gout derived from administrative health data in Aotearoa New Zealand. Rheumatology (Oxford) 2012;51:901–909.</p>
 <p data-pid="ADCN2m8V">107. Lee C-YJ, Isaac HB, Huang SH, Long LH, Wang H, Gruber J, et al. Limited antioxidant effect after consumption of a single dose of tomato sauce by young males, despite a rise in plasma lycopene. Free Radic Res. 2009;43:622–628.</p>
 <p data-pid="_y_DXf7p">108. Johnson RJ, Nakagawa T, Sanchez-Lozada LG, Lanaspa MA, Tamura Y, Tanabe K, et al. Umami: the taste that drives purine intake. J Rheumatol. 2013;40:1794–1796.</p>
 <p data-pid="sW3-raid">109. Raivio KO, Seegmiller JE. Role of glutamine in purine synthesis and in guanine nucleotide formation in normal fibroblasts and in fibroblasts deficient in hypoxanthine phosphoribosyltransferase activity. Biochim Biophysic Acta. 1973;299:283–292.</p>
 <p data-pid="4z-DlVYD">110. Tanya J Flynn, Murray Cadzow, Nicola Dalbeth, Peter B Jones, Lisa K Stamp, Jennie Harré Hindmarsh, Alwyn S Todd, Robert J Walker, Ruth Topless, and Tony R Merrimancorresponding author.Positive association of tomato consumption with serum urate: support for tomato consumption as an anecdotal trigger of gout flares.BMC Musculoskelet Disord. 2015; 16: 196.</p>
 <p data-pid="dDD3NoEe">111. Maersk M., Belza A., Stødkilde-Jorgensen H., Ringgaard S., Chabanova E., Thomsen H., Pedersen S. B., Astrup A., and Richelsen B. (2012) Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study. Am. J. Clin. Nutr. 95, 283–289</p>
 <p data-pid="g3zPRISE">112. Ackerman Z., Oron-Herman M., Grozovski M., Rosenthal T., Pappo O., Link G., and Sela B. A. (2005) Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction. Hypertension 45, 1012–1018 10.1161/01.HYP.</p>
 <p data-pid="JgPLDtRf">113. Ishimoto T., Lanaspa M. A., Le M. T., Garcia G. E., Diggle C. P., Maclean P. S., Jackman M. R., Asipu A., Roncal-Jimenez C. A., Kosugi T., Rivard C. J., Maruyama S., Rodriguez-Iturbe B., Sánchez-Lozada L. G., Bonthron D. T., et al. (2012) Opposing effects of fructokinase C and A isoforms on fructose-induced metabolic syndrome in mice. Proc. Natl. Acad. Sci. U.S.A. 109, 4320–4325.</p>
 <p data-pid="mJ5HumYy">114. Lanaspa M. A., Ishimoto T., Li N., Cicerchi C., Orlicky D. J., Ruzycki P., Rivard C., Inaba S., Roncal-Jimenez C. A., Bales E. S., Diggle C. P., Asipu A., Petrash J. M., Kosugi T., Maruyama S., et al. (2013) Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome. Nat. Commun. 4, 2434</p>
 <p data-pid="PLsryobg">115. Lanaspa M. A., Kuwabara M., Andres-Hernando A., Li N., Cicerchi C., Jensen T., Orlicky D. J., Roncal-Jimenez C. A., Ishimoto T., Nakagawa T., Rodriguez-Iturbe B., MacLean P. S., and Johnson R. J. (2018) High salt intake causes leptin resistance and obesity in mice by stimulating endogenous fructose production and metabolism. Proc. Natl. Acad. Sci. U.S.A. 115, 3138–3143</p>
 <p data-pid="8qq08eXj">116. Na K. Y., Woo S. K., Lee S. D., and Kwon H. M. (2003) Silencing of TonEBP/NFAT5 transcriptional activator by RNA interference. J. Am. Soc. Nephrol. 14, 283–288.</p>
 <p data-pid="TZNLLm1R">117. Woo S. K., Lee S. D., and Kwon H. M. (2002) TonEBP transcriptional activator in the cellular response to increased osmolality. Pflugers Arch. 444, 579–585</p>
 <p data-pid="BtfasEz0">118. Lanaspa M. A., Sanchez-Lozada L. G., Cicerchi C., Li N., Roncal-Jimenez C. A., Ishimoto T., Le M., Garcia G. E., Thomas J. B., Rivard C. J., Andres-Hernando A., Hunter B., Schreiner G., Rodriguez-Iturbe B., Sautin Y. Y. et al. (2012) Uric acid stimulates fructokinase and accelerates fructose metabolism in the development of fatty liver. PLoS One 7, e47948</p>
 <p data-pid="DRZ58Sp8">119. Wu XW, Muzny DM, Lee CC, Caskey CT. Two independent mutational events in the loss of urate oxidase during hominoid evolution.<i>J Mol Evol.</i>1992;</p>
 <p data-pid="Fm3kzRz8">120. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging.<i>Proc Natl Acad Sci U S A.</i>1993;90:7915–22.</p>
 <p data-pid="4RM9FnRv">121. Becker BF. Towards the physiological function of uric acid.<i>Free Radic Biol Med.</i>1993;14:615–31.</p>
 <p data-pid="qCGXMW64">122. Maples KR, Mason RP. Free radical metabolite of uric acid.<i>J Biol Chem.</i>1988;263:1709–12.</p>
 <p data-pid="9W25aY5K">123. Sevanian A, Davies KJ, Hochstein P. Conservation of vitamin C by uric acid in blood.<i>J Free Radic Biol Med.</i>1985;1:117–24.</p>
 <p data-pid="xkk1oZvy">124. Davies KJ, Sevanian A, Muakkassah-Kelly SF, Hochstein P. Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid.<i>Biochem J.</i>1986;235:747–54.</p>
 <p data-pid="UoJZfOcD">125. Johnson RJ, Andrews P. Fructose, Uricase, and the Back to Africa Hypothesis. Evol Anthro. 2010 in press.</p>
 <p data-pid="lGXyVd0v">126. Ellis H. A study of British genius. London: Hurst and Blackett; 1903</p>
 <p data-pid="p1zGWmcz">127. Wenqiang Zhang and Rongsheng Luan.Early-life exposure to the Chinese famine of 1959–61 and risk of Hyperuricemia: results from the China health and retirement longitudinal study BMC Public Health (2020) 20:15.</p>
 <p data-pid="uFlzJxA7">128. Mesquita FF, Gontijo JA, Boer PA. Maternal undernutrition and the offspring kidney: from fetal to adult life. Braz J Med Biol Res. 2010;43(11):1010–1018.</p>
 <p data-pid="wNKuXIM3">129. Pham TD, MacLennan NK, Chiu CT, Laksana GS, Hsu JL, Lane RH. Uteroplacental insufficiency increases apoptosis and alters p53 gene methylation in the full-term IUGR rat kidney. Am J Physiol Regul Integr</p>
 <p data-pid="2i5SsJSo">CompPhysiol. 2003;285(5):R962–R970.</p>
 <p data-pid="Jw00lVxk">130. Franco M. Intrauterine undernutrition—renal and vascular origin of hypertension. Cardiovasc Res. 2003;60(2):228–234.</p>
 <p data-pid="wWY6uX-x">131. Lennox WG. Increase of uric acid in the blood during prolonged starvation. J Am Med Assoc. 1924;82:602–604.</p>
 <p data-pid="O_k_EqtC">132. Murphy R, Shipman KH. Hyperuricemia during Total fasting: renal factors. Arch Intern Med. 1963;112:954–959.</p>
 <p data-pid="XyiyaFNr">133. Lennox WG. A study of the retention of uric acid during starvation. J Biol Chem. 1925;66:521–572.</p>
 <p data-pid="y40KoB30">134. Alderman MH, Davis RP. Hyperuricemia in starvation. P Soc Exp Biol Med. 1965;118(3):790–792.</p>
 <p data-pid="FU19rgMw">135. Drenick EJ. Hyperuricemia, acute gout, renal insufficiency and urate nephrolithiasis due to starvation. Arthritis Rheum. 1965;8:988–997.</p>
 <p data-pid="5L6VGtjn">136. Lennox WG. Increase of uric acid in the blood during prolonged starvation. J Am Med Assoc. 1924;82:602–604.</p>
 <p data-pid="P2YiNRx0">137. Lloydmostyn RH, Lord PS, Glover R, West C, Gilliland IC. Uric acid metabolism in starvation. Ann Rheum Dis. 1970;29(5):553–555.</p>
 <p data-pid="LFPUEUfh">138. Quinones Galvan A, Natali A, Baldi S, Frascerra S, Sanna G, Ciociaro D, Ferrannini E. Effect of insulin on uric acid excretion in humans. Am J Phys. 1995;268(1 Pt 1):E1–E5.</p>
 <p data-pid="_u_tb05F">139. Ter Maaten JC, Voorburg A, Heine RJ, Ter Wee PM, Donker AJ, Gans RO. Renal handling of urate and sodium during acute physiological hyperinsulinaemia in healthy subjects. Clin Sci (Lond) 1997;92(1):51–58.</p>
 <p data-pid="vBqbWRjR">140. Lim SM, Choi DP, Rhee Y, Kim HC. Association between obesity indices and insulin resistance among healthy Korean adolescents: the JS high school study. PLoS One. 2015;10(5):e0125238.</p>
 <p data-pid="E3-0r9sP">141. Yamashita S, Matsuzawa Y, Tokunaga K, Fujioka S, Tarui S. Studies on the impaired metabolism of uric acid in obese subjects: marked reduction of renal urate excretion and its improvement by a low-calorie diet. Int J Obes. 1986;10(4):255–264.</p>
 <p data-pid="aRKSRkmM">142. Becker B.F. Towards the physiological function of uric acid. Free Radic. Biol. Med. 1993;14:615–631.</p>
 <p data-pid="7BVPvBzP">143. Hink H.U., Fukai T. Extracellular superoxide dismutase, uric acid, and atherosclerosis. Cold Spring Harb. Symp. Quant. Biol. 2002;67:483–490.</p>
 <p data-pid="pEpajkdz">144. Hink H.U., Santanam N., Dikalov S., McCann L., Nguyen A.D., Parthasarathy S., Harrison D.G., Fukai T. Peroxidase properties of extracellular superoxide dismutase: Role of uric acid in modulating in vivo activity. Arterioscler. Thromb. Vasc. Biol. 2002;22:1402–1408.</p>
 <p data-pid="YdlAlz-E">145. Simic M.G., Jovanovic S.V. Antioxidation mechanisms of uric acid. J. Am. Chem. Soc. 1989;111:5778–5782.</p>
 <p data-pid="AIRWgQQh">146. Waring W.S. Uric acid: An important antioxidant in acute ischaemic stroke. QJM. 2002;95:691–693.</p>
 <p data-pid="EAIpJxKD">147. Waring W.S., Convery A., Mishra V., Shenkin A., Webb D.J., Maxwell S.R. Uric acid reduces exercise-induced oxidative stress in healthy adults. Clin. Sci. (Lond.) 2003;105:425–430.</p>
 <p data-pid="8bzlO-k5">148. Waring W.S., Maxwell S.R., Webb D.J. Uric acid concentrations and the mechanisms of cardiovascular disease. Eur. Heart J. 2002;23:1888–1889.</p>
 <p data-pid="DWM9m4N2">149. Waring W.S., McKnight J.A., Webb D.J., Maxwell S.R. Uric acid restores endothelial function in patients with type 1 diabetes and regular smokers. Diabetes. 2006;55:3127–3132.</p>
 <p data-pid="cku9ffEz">150. Waring W.S., Webb D.J., Maxwell S.R. Systemic uric acid administration increases serum antioxidant capacity in healthy volunteers. J. Cardiovasc. Pharmacol. 2001;38:365–371.</p>
 <hr>
 <p></p>
</body>